Pharmacogenetics of new oral anticoagulants

The review presents modern studies the effect of genetic polymorphisms on the efficienty and safety of therapy with new oral anticoagulants. Hepatic carboxylesterase encoded by the CES1 gene and P-glycoprotein encoded by the ABCB1 gene affect dabigatran pharmacokinetics. The role of glucuronidation...

書目詳細資料
發表在:	КардиоСоматика
Main Authors:	Bella A. Azimova, Konstsantin Yu. Nikolayev, Anton S. Vorobyov, Irina A. Urvantseva
格式:	Article
語言:	英语
出版:	Concilium Medicum 2023-04-01
主題:	dabigatran apixaban rivaroxaban pharmacogenetics efficiency safety
在線閱讀:	https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/107195/pdf_2

相似書籍

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
由: A. V. Kryukov, et al.
出版: (2017-07-01)

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
由: Natalia A. Shnayder, et al.
出版: (2021-04-01)

DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS
由: S. N. Bel'diev, et al.
出版: (2017-11-01)

Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants
由: Ju Yup Lee
出版: (2018-12-01)

Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology
由: Sergey N. Bel'diev, et al.
出版: (2019-05-01)

Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology
由: Sergey N. Bel'diev, et al.
出版: (2019-05-01)

New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants
由: K. B. Mirzaev, et al.
出版: (2020-11-01)

Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells
由: Sergey Nikolaevich Bel'diev, et al.
出版: (2017-11-01)

Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells
由: Sergey Nikolaevich Bel'diev, et al.
出版: (2017-11-01)

Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology
由: S. N. Bel'diev, et al.
出版: (2019-05-01)

Are outpatient anticoagulation management services the wave of the future (again)?
由: Bethany Samuelson Bannow
出版: (2022-05-01)

A Combination of Ex Vivo and In Vivo Strategies for Evaluating How Much New Oral Anticoagulants Exacerbate Experimental Intracerebral Bleeding
由: Ferreira Ferreira, et al.
出版: (2023-07-01)

Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows
由: Luca Masotti, et al.
出版: (2012-10-01)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
由: Tomas L. Lindahl, et al.
出版: (2017-07-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
由: D. A. Napalkov, et al.
出版: (2015-09-01)

Assessment and predictors of inappropriate dose of direct oral anticoagulants
由: Mosaad O. Almegren
出版: (2024-01-01)

Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers
由: Ramin Artang, et al.
出版: (2019-07-01)

Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022
由: A. V. Matveev, et al.
出版: (2024-01-01)

Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review
由: B. A. Tatarsky, et al.
出版: (2022-11-01)

COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS
由: V. A. Sulimov, et al.
出版: (2015-09-01)

Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants
由: Yoshinari Morimoto, et al.
出版: (2016-03-01)

Clinical outcomes of direct oral anticoagulant off-label dosing in nonvalvular atrial fibrillation
由: M. Jansson, et al.
出版: (2025-09-01)

Effect of systemic anticoagulants on fracture healing in rats tibia
由: Murat Tanrisever, et al.
出版: (2025-10-01)

Direct oral anticoagulants: efficacy and safety in patient subgroups
由: Thomas A. Mavrakanas, et al.
出版: (2015-01-01)

Direct oral anticoagulants: a guide for daily practice
由: Pierre Fontana, et al.
出版: (2016-02-01)

IMPACT OF NON-VITAMIN K ORAL ANTI-COAGULANTS ON WARFARIN UTILISATION AND NHS BUDGET IN UK
由: Mohammed Aladul, et al.
出版: (2022-09-01)

Hepatotoxicity of New Oral Anticoagulants
由: A. R. Kasimova, et al.
出版: (2018-09-01)

Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art
由: S. R. Gilyarevsky
出版: (2022-07-01)

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
由: Tommaso Sacquegna, et al.
出版: (2015-12-01)

Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation
由: Luca Masotti, et al.
出版: (2013-12-01)

The treatment of venous thromboembolism with new oral anticoagulants
由: Davide Imberti
出版: (2013-12-01)

Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
由: Nicola Ferri, et al.
出版: (2022-05-01)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
由: Z. D. Kobalava, et al.
出版: (2021-03-01)

DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT
由: D. А. Napalkov, et al.
出版: (2017-03-01)

Is There an Alternative Oral Anticoagulation to Vitamin-K-Antagonists for Patients with Mechanical Aortic Valve Replacement? – A Literature Review
由: Stephen Gerfer, et al.
出版: (2024-05-01)

The New Oral Anticoagulants for the Treatment of Venous Thromboembolism: A New Paradigm Shift in Antithrombotic Therapy
由: Taki Galanis, MD, et al.
出版: (2014-12-01)

ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
由: A. V. Rudakova
出版: (2015-09-01)

Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true
由: Yu. A. Bunin, et al.
出版: (2016-09-01)

Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice
由: A. A. Zarudsky, et al.
出版: (2020-03-01)

HOW NEW APPROACHES TO THE TREATMENT OF PULMONARY EMBOLISM AFFECT THE OUTCOME OF THE DISEASE?
由: M. Y. Gilyarov, et al.
出版: (2017-12-01)